From Crisis Aversion to Cost Reduction - Managed Care Insights on Enhancing Ketone Monitoring for Diabetic Ketoacidosis Prevention

Program Description

Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes, often occurring in people with type 1 diabetes, though there is a rising prevalence among individuals with type 2 diabetes in certain situations, such as with the use of SGLT2 inhibitors or during pregnancy. Delayed treatment of DKA can result in increased readmission, complications, and a significant economic burden on the healthcare system. Managing DKA effectively requires careful monitoring of ketones, but current methods for monitoring DKA are inconsistent and often inaccurate. Managed care professionals should be aware of DKA monitoring developments and integrate continuous ketone monitoring with glucose monitoring to improve patient outcomes, decrease the risk of complications, and reduce health care resource utilization. Recent advancements in continuous ketone monitoring being integrated with a continuous glucose monitoring system have the potential to transform DKA management by reducing delayed diagnoses and enhancing patient safety. This supplement will present the most recent data available on emerging ketone monitoring technology, and contextualize the importance of reducing the incidence of DKA in populations at high risk for managed care professionals.

Target audience: Managed care pharmacists

Type of activity: Application

Release date: April 1, 2026

Expiration date: April 1, 2027

Learner level: Foundational, Intermediate, Advanced

Time to complete activity: 3.0 hours

Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Identify risk factors and populations at high risk for diabetic ketoacidosis (DKA)
• Illustrate the societal, economic, and clinical burden of DKA on patients and the health care system.
• Examine approaches for ketone monitoring, interpretation, and utility in the prevention and management of DKA.
• Analyze the potential cost-effectiveness of continuous ketone monitoring (CKM) compared with traditional DKA monitoring methods and the role of CKM to improve patient outcomes.